Cholecalciferol Supplementation Does Not Prevent the Development of Metabolic Syndrome or Enhance the Beneficial Effects of Omega-3 Fatty Acids in Obese Mice.

Marion VallePatricia L MitchellGeneviève PilonPhilippe St-PierreThibault VarinDenis RichardMarie-Claude VohlHélène JacquesEdgar DelvinEmile LevyClaudia GagnonLaurent BazinetAndré Marette

Published in: The Journal of nutrition (2021)

Overall, D3 supplementation does not prevent CMD or enhance the beneficial effects of ω-3FA in vitamin D-sufficient obese mice.

Keyphrases

metabolic syndrome
fatty acid
insulin resistance
uric acid
cardiovascular disease
adipose tissue
skeletal muscle